Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Net Income: 2010-2021

Historic Net Income for Neurocrine Biosciences (NBIX) over the last 12 years, with Sep 2021 value amounting to $22.5 million.

  • Neurocrine Biosciences' Net Income rose 139.06% to $22.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $39.3 million, marking a year-over-year decrease of 57.93%. This contributed to the annual value of $37.0 million for FY2019, which is 75.32% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Net Income stood at $22.5 million, which was down 46.81% from $42.3 million recorded in Q2 2021.
  • Neurocrine Biosciences' Net Income's 5-year high stood at $79.6 million during Q2 2020, with a 5-year trough of -$102.1 million in Q1 2019.
  • Moreover, its 3-year median value for Net Income was $35.7 million (2019), whereas its average is $19.3 million.
  • Its Net Income has fluctuated over the past 5 years, first slumped by 293.66% in 2017, then surged by 967.58% in 2019.
  • Over the past 5 years, Neurocrine Biosciences' Net Income (Quarterly) stood at $6.9 million in 2017, then surged by 172.82% to $18.8 million in 2018, then spiked by 80.84% to $34.0 million in 2019, then slumped by 207.06% to -$57.6 million in 2020, then soared by 139.06% to $22.5 million in 2021.
  • Its Net Income was $22.5 million in Q3 2021, compared to $42.3 million in Q2 2021 and $32.1 million in Q1 2021.